Pharmaceuticals by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Travere Therapeutics leads the 39 pharmaceuticals ranked by P/B ratio, at 217, ahead of Arrowhead Pharmaceuticals (121) and Rhythm Pharmaceuticals (91.9). Figures as of 18 Nov 2026, 13:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
39
First
Travere Therapeutics217
Median
6.8
Combined market value
$5.16T
Countries
10
Not ranked
22no P/B ratio on file

Market values as of .

Pharmaceuticals by P/B ratio
#CompanyP/B ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Travere TherapeuticsTVTX · Health Care217$4.9B$51.10 2.82% up 44% up United States
2Arrowhead PharmaceuticalsARWR · Health Care121$6.1B$42.99 2.76% down 10% up United States
3Rhythm PharmaceuticalsRYTM · Health Care91.9$8.1B$116.61 8.49% up 13% up United States
4Axsome TherapeuticsAXSM · Health Care67.8$7.2B$135.95 0.77% down 7% down United States
5InsmedINSM · Health Care36.8$26.7B$121.86 0.83% down 40% down United States
6Eli LillyLLY · Health Care31.3$1.26T$1,415.55 1.13% down 35% up United States
7Madrigal PharmaceuticalsMDGL · Health Care15.6$9.8B$421.99 0.46% down 24% down United States
8TG TherapeuticsTGTX · Health Care15.4$9.5B$62.71 0.08% down 107% up United States
9Summit TherapeuticsSMMT · Health Care15.1$8.5B$10.67 9.73% down 36% down United States
10Amneal PharmaceuticalsAMRX · Health Care13.8$7.4B$21.12 0.52% down 83% up United States
11Ionis PharmaceuticalsIONS · Health Care11.4$4.5B$26.96 3.75% down 64% down United States
12Cogent BiosciencesCOGT · Health Care10.7$4.8B$27.85 1.49% up 20% down United States
13ZoetisZTS · Health Care10.3$33.9B$83.48 1.08% down 29% down United States
14Spyre TherapeuticsSYRE · Health Care9.3$8.9B$93.81 5.60% down 286% up United States
15Corcept TherapeuticsCORT · Health Care9.2$7.7B$70.07 1.23% up 8% down United States
16Johnson & JohnsonJNJ · Health Care8.2$670.9B$278.70 1.36% down 38% up United States
17Belite BioBLTE · Health Care8.1$6.4B$157.72 2.98% down 31% up United States
18Merck & CoMRK · Health Care7.9$353.4B$143.37 0.75% down 51% up United States
19Protagonist TherapeuticsPTGX · Health Care7.5$8.1B$124.67 0.13% down 46% up United States
20Praxis Precision MedicinesPRAX · Health Care6.8$8.5B$305.06 1.68% down 61% up United States
21VeradermicsMANE · Health Care6.7$5.3B$125.64 1.88% down 233% up United States
22Vertex PharmaceuticalsVRTX · Health Care6.5$135.4B$534.20 0.67% down 27% up United States
23Ligand PharmaceuticalsLGND · Health Care6.1$5.9B$293.81 2.62% down 43% up United States
24Alnylam PharmaceuticalsALNY · Health Care5.8$21B$156.50 2.02% down 66% down United States
25Oruka TherapeuticsORKA · Health Care5.4$6.5B$96.32 2.94% down 241% up United States
26Bristol-Myers SquibbBMY · Health Care5.4$125.4B$61.35 2.51% down 34% up United States
27ErascaERAS · Health Care5.3$4.9B$13.89 8.07% down 403% up United States
28Royalty PharmaRPRX · Health Care4.5$39.5B$68.68 0.23% up 78% up United States
29Definium TherapeuticsDFTX · Health Care4.2$4B$29.38 2.59% down 169% up United States
30United TherapeuticsUTHR · Health Care3.9$24.9B$584.10 0.64% down 23% up United States
31Dianthus TherapeuticsDNTH · Health Care3.9$4.9B$86.98 2.87% down 113% up United States
32Abbott LaboratoriesABT · Health Care3.6$181.4B$104.71 2.55% down 17% down United States
33Regeneron PharmaceuticalsREGN · Health Care2.9$99.1B$957.76 0.56% up 36% up United States
34Edgewise TherapeuticsEWTX · Health Care2.8$4.6B$42.04 3.75% down 88% up United States
35Legend BiotechLEGN · Health Care2.5$3.1B$16.11 0.75% up 42% down United States
36Elanco Animal HealthELAN · Health Care1.9$12.9B$25.85 2.12% down 20% up United States
37PfizerPFE · Health Care1.8$162.3B$28.47 1.35% down 14% up United States
38BioMarin PharmaceuticalBMRN · Health Care1.8$11.3B$58.51 0.90% up 11% up United States
39ViatrisVTRS · Health Care1.7$23.4B$20.45 1.40% down 96% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 22 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which pharmaceuticals rank first by P/B ratio?

Travere Therapeutics (217), Arrowhead Pharmaceuticals (121) and Rhythm Pharmaceuticals (91.9) are the top three of the 39 pharmaceuticals ranked by P/B ratio as of 18 Nov 2026, 13:49 UTC.

How many pharmaceuticals are in this ranking?

39 are ranked by P/B ratio. 22 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these pharmaceuticals worth together?

The 39 pharmaceuticals ranked by P/B ratio have a combined market value of $5.16T as of 18 Nov 2026, 13:49 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Pharmaceuticals by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.